The authors reported that there was a highly significant monotonic relationship between low LDL-C levels and a lower risk of the primary and secondary efficacy composite endpoints (LDL-C concentrations of less than 0.2 mmol/L; p = 0.0012 for the primary endpoint, p = 0.0001 for the secondary endpoint) [ 56 ].
← all excerpts
Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs.
1
—
—